Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831882 · ClinicalTrials.gov registry record
Identifying Biological Markers for Severe Depression
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 210
- Enrollment target
NCT01831882 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 210 participants.
The verdict
NCT01831882 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
Study Summary
The primary objective of this study is to investigate the biological components of major depression. The investigators are particularity interested in genetic variation and how it contributes to cortisol (because cortisol is higher in severe depression than mild depression or healthy controls) and how it contributes to clinical symptoms, especially suicidal ideation/behavior and psychosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2013-07 |
| Est. Completion | 2020-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01831882
The ClinicalTrials.gov registry entry for NCT01831882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01831882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01831882 about?
NCT01831882 is a clinical study titled "Identifying Biological Markers for Severe Depression". The primary objective of this study is to investigate the biological components of major depression. The investigators are particularity interested in genetic variation and how it contributes to cortisol (because cortisol is higher in severe depression than mild depression or healthy controls) and h...
What is the current status of trial NCT01831882?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2013-07. Estimated completion is 2020-08.
Who is sponsoring clinical trial NCT01831882?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.